Search

Search Constraints

You searched for: Author/Creator Lugtenburg, Pieternella J.

Search Results

1. A population-based study on different regimens of R-CHOP in patients with newly diagnosed DLBCL in The Netherlands. Issue 3 (23rd February 2021)

2. ABVD or BEACOPPbaseline along with involved-field radiotherapy in early-stage Hodgkin Lymphoma with risk factors: Results of the European Organisation for Research and Treatment of Cancer (EORTC)–Groupe d'Étude des Lymphomes de l'Adulte (GELA) H9-U intergroup randomised trial. (August 2017)

3. Bortezomib maintenance after R‐CHOP, cytarabine and autologous stem cell transplantation in newly diagnosed patients with mantle cell lymphoma, results of a randomised phase II HOVON trial. (9th March 2020)

4. Clinicopathological features and risk factors for developing colorectal neoplasia in Hodgkin's lymphoma survivors. Issue 1 (8th June 2021)

5. Development and Validation of Risk Prediction Models for Coronary Heart Disease and Heart Failure After Treatment for Hodgkin Lymphoma. Issue 1 (1st January 2023)

6. Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy Toxicities. Issue 3 (12th December 2022)

7. Earlier corticosteroid use for adverse event management in patients receiving axicabtagene ciloleucel for large B‐cell lymphoma. (29th September 2021)

8. Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell–Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial. Issue 12 (20th April 2023)

9. High prevalence of advanced colorectal neoplasia and serrated polyposis syndrome in Hodgkin lymphoma survivors. Issue 6 (18th December 2018)

10. Improved survival for adolescents and young adults with Hodgkin lymphoma and continued high survival for children in the Netherlands: a population‐based study during 1990–2015. (6th February 2020)